The Diagnostic Electrocardiograph Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Diagnostic Electrocardiograph Market:
https://www.thebusinessresearchcompany.com/report/diagnostic-electrocardiograph-global-market-report
According to The Business Research Company’s Diagnostic Electrocardiograph Global Market Report 2024, The diagnostic electrocardiograph market size has grown strongly in recent years. It will grow from $7.59 billion in 2023 to $8.12 billion in 2024 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to the aging global population, increased incidence of cardiovascular diseases, rising healthcare expenditure globally, increasing awareness and screening programs for cardiovascular health, and regulatory support for early diagnosis and treatment of cardiac conditions.
The diagnostic electrocardiograph market size is expected to see strong growth in the next few years. It will grow to $10.66 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to the expansion of healthcare infrastructure in emerging markets, regulatory initiatives, rising awareness and proactive health management among consumers, increasing investments in healthcare, and a and a rising geriatric population. Major trends in the forecast period include the integration of artificial intelligence (AI), portable and wireless ECG devices, the adoption of telehealth, advancements in wearable ECG technology, and personalized medicine.
The increasing prevalence of heart disorders globally is expected to propel the growth of the diagnostic electrocardiograph market going forward. Heart disorders encompass a range of conditions affecting the cardiovascular system, from arrhythmias and heart attacks to congenital defects and heart failure. The cases of heart disorders can be attributed to several factors, including aging populations, sedentary lifestyles, and unhealthy dietary habits, which contribute to rising rates of obesity and hypertension, major risk factors for heart conditions. Diagnostic electrocardiography (ECG) plays a crucial role in the increasing prevalence of heart disorders globally by enabling early detection, monitoring, and management of cardiac conditions through non-invasive electrical activity assessments. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, In the cardiovascular sector, there was a slight increase in the total number of deaths this year, reaching 931,578, which represents a marginal rise of 3,000 fatalities compared to the previous year’s figure of 928,741. Therefore, the increasing prevalence of heart disorders globally will drive the growth of the diagnostic electrocardiograph market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=18333&type=smp
The diagnostic electrocardiograph market covered in this report is segmented –
1) By Product And Service: Resting Electrocardiogram (ECG), Stress Electrocardiogram (ECG) Devices, Holter Monitors, Implantable Loop Recorders, Event Monitors, Mobile Cardiac Telemetry (MCT) Devices, Smart Electrocardiogram (ECG) Monitors
2) By Lead Type: 12 Lead, 5 Lead, 3 Lead, Other Lead Types
3) By End-User: Hospitals, Clinics And Cardiac Centers, Ambulatory Surgical Centers, Other End Users
Major companies operating in the diagnostic electrocardiograph market are focusing on advanced technologies, such as AI-powered ECG systems, to enhance accuracy and efficiency in diagnosing cardiac conditions. An advanced artificial intelligence system integrated into an ECG device enhances diagnostic accuracy and efficiency in cardiovascular healthcare settings. For instance, in June 2024, AliveCor, a US-based medical technology company, launched its KAI 12L AI technology alongside the Kardia 12L ECG System. This groundbreaking innovation is the world’s first AI capable of detecting critical cardiac conditions, including heart attacks, using a simplified leadset. The new ECG System, leveraging patented technology, represents the world’s first handheld 12-lead ECG system powered by AI, featuring a distinctive single-cable design.
The diagnostic electrocardiograph market report table of contents includes:
1. Executive Summary
2. Diagnostic Electrocardiograph Market Characteristics
3. Diagnostic Electrocardiograph Market Trends And Strategies
4. Diagnostic Electrocardiograph Market – Macro Economic Scenario
5. Global Diagnostic Electrocardiograph Market Size and Growth
.
.
.
32. Global Diagnostic Electrocardiograph Market Competitive Benchmarking
33. Global Diagnostic Electrocardiograph Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Diagnostic Electrocardiograph Market
35. Diagnostic Electrocardiograph Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
